The single-breath carbon monoxide diffusing capacity (DL CO ) is the product of two measurements during breath holding at full inflation: (1) the rate constant for carbon monoxide uptake from alveolar gas (kCO [minute 21 ]) and (2) the "accessible" alveolar volume (VA). kCO expressed per mm Hg alveolar dry gas pressure (Pb*) as kCO/Pb*, and then multiplied by VA, equals DL CO ; thus, DL CO divided by VA (DL CO /VA, also called KCO) is only kCO/Pb* in different units, remaining, essentially, a rate constant. The notion that DL CO /VA "corrects" DL CO for reduced VA is physiologically incorrect, because DL CO /VA is not constant as VA changes; thus, the term KCO reflects the physiology more appropriately. Crucially, the same DL CO may occur with various combinations of KCO and VA, each suggesting different pathologies. Decreased KCO occurs in alveolar-capillary damage, microvascular pathology, or anemia. Increased KCO occurs with (1) failure to expand normal lungs to predicted full inflation (extrapulmonary restriction); or (2) increased capillary volume and flow, either globally (left-toright intracardiac shunting) or from flow and volume diversion from lost or damaged units to surviving normal units (e.g., pneumonectomy). Decreased VA occurs in (1) reduced alveolar expansion, (2) alveolar damage or loss, or (3) maldistribution of inspired gases with airflow obstruction. KCO will be greater than 120% predicted in case 1, 100-120% in case 2, and 40-120% in case 3, depending on pathology. KCO and VA values should be available to clinicians, as fundamental to understanding the clinical implications of DL CO . The diffusing capacity for nitric oxide (DL NO ), and the DL NO /DL CO ratio, provide additional insights.
The single-breath diffusing capacity for carbon monoxide (DL CO ) (known in Europe as the transfer factor, TL CO ) is, after spirometry and lung volumes, the most clinically useful routine pulmonary function test. The DL CO , as pointed out by its originator, Marie Krogh (1) , is the product of two separate but simultaneous measurements ( Figure 1 ): the rate constant kCO (the rate of uptake of CO from alveolar gas), and the alveolar volume (VA). The important point is that KCO (kCO reexpressed per mm Hg alveolar PCO) is linearly related to the alveolar uptake efficiency for carbon monoxide (2, 3) . Because of the special properties of carbon monoxide, KCO directly reflects the quality of alveolar-capillary gas uptake. Many articles and pulmonary function testing (PFT) laboratories do not quote VA and KCO from which the DL CO is derived; this may result in significant loss of clinical information.
MEASUREMENT OF KCO AND VA

Rate of Uptake of Alveolar Carbon Monoxide (kCO)
During breath holding in the single-breath DL CO , CO is removed from alveolar gas at an exponential rate [log e (CO 0 /CO t )/BHT], where CO 0 and CO t are the alveolar concentrations at the start and finish of the breath-holding time (BHT). This expression is a rate constant with units of minute 21 or second
21
; in Figure 1 it is represented by the slope, kCO.
Alveolar Volume (VA)
The DL CO is measured during breath holding at full inflation; in absolute terms, this represents total lung capacity (TLC). The lung volume during breath holding is measured simultaneously by dilution of any nonabsorbable gas, most commonly helium (He) (Figure 1 ), at the same time as the kCO is measured (4) . The alveolar volume (VA) is an "accessible" volume, that is, that seen by the gas-exchanging surface, derived from the single-breath helium dilution volume after subtracting an "estimated" anatomic dead space (VDanat) from the inspired volume (VI) (Figure 1 ). The VI starts from residual volume and finishes at maximal inflation (zTLC); the inspiration should be made as rapidly as possible. In normal subjects, VA is within 10% of TLC, with a mean VA/TLC ratio (combining men and women) of 93.5% 6 6.6 (1 SD) (5) ; the VA/TLC ratio has no significant dependence on age, sex, height, or weight (5), but decreases substantially when there is intrapulmonary airflow obstruction and maldistribution of ventilation. VDanat represents 2-3% of the TLC in normal subjects, the remaining 4% of the VA/TLC difference occurring because gas mixing in the 10-second breath hold is incomplete. In disease, the difference between the single-breath VA and the multibreath or plethysmographic TLC, and the VA/TLC ratio, deserves more study (5) as an index of gas mixing efficiency.
Combining VA and kCO where kCO is the fractional change in CO concentration, expressed in minute
21
, and _ VCO is the uptake of CO from alveolar gas during breath holding at TLC. Equation 1 gives a large value for _ VCO because, as pointed out by Marie Krogh (1) , the calculation implies that all alveolar gas is pure CO. For the second step, to obtain DL CO where _ VCO/Pb* is the alveolar CO uptake per minute per mm Hg PCO, which, as a conductance, defines the DL CO . In pulmonary function reports DL CO is divided by VA with ml STPD exchanged for L BTPS:
where DL CO /VA and KCO have units of ml minute 21 mm Hg 21 L
, 1,000 converts milliliters to liters, and 1.2 is the STPD-to-BTPS factor. These units, as reported in pulmonary function laboratories, give the impression of a volume "adjustment," leading to much confusion, whereas it is obvious from equation 3 that kCO (the rate constant) only differs from DL CO /VA (¼ KCO) by three constant factors (Pb*, 1,000, and 1.2) and in its units. The ratios DL CO /VA (¼ KCO) to kCO and to kCO/Pb* (both constant except for minor variations in Pb) are given in the legend to Figure 1 . Therefore, DL CO /VA (¼ KCO) is effectively the rate constant, representing alveolar carbon monoxide uptake efficiency. Unless required by the context, this review uses the term KCO in preference to DL CO /VA.
WHAT DOES THE KCO SIGNIFY?
The previous section has shown that kCO (second 21 BTPS) are physiologically equivalent, except in their units, to the rate of removal of CO from alveolar gas, that is, the slope (on a semilogarithmic plot) of carbon monoxide uptake in Figure 1 , labeled kCO. KCO, expressed as kCO, is the rate constant for alveolar CO uptake; KCO, expressed as DL CO /VA, is the carbon monoxide diffusing capacity per unit alveolar volume, at the alveolar volume (VA) at which the measurement is made; it remains, in essence, a pressure-adjusted rate constant for alveolar carbon monoxide uptake. The difficulty, or confusion, stems from the notion that "per unit volume" implies DL CO corrected for lung volume, a concept that is wrong because DL CO measured at a different volume, at a different level of VA/ VA TLC , would yield a different value for DL CO /VA (¼ KCO) (see Figures 2 and 3) . Paradoxically, DL CO /VA contains no information about the value of VA, being a weighted mean value of the rate of CO uptake in the "accessible" VA. Therefore, it would be prudent to replace the misleading (although physiologically correct) "diffusing capacity per unit alveolar volume" by KCO, which, unlike the earlier term kCO, is numerically the same as DL CO /VA.
How should the KCO be defined? Krogh (1) called k (¼ kCO) "permeability," and KCO has been referred to as the Krogh factor (6). Cotes (7) and others (8) refer to TL CO /VA (zDL CO /VA) as the "transfer coefficient." Hughes and Pride (2) referred to KCO as "essentially the rate constant for alveolar CO uptake." No clarifying definition has emerged from the American Thoracic Society/European Respiratory Society (ATS/ERS) Task Force on Standardization of Lung Function Testing (9, 10) , who still refer to KCO or DL CO /VA, like most authors, as "diffusing capacity per unit alveolar volume." We regard the KCO as an index of the efficiency of alveolar transfer of carbon monoxide (approximately the rate of CO uptake); "transfer" is a better term than "diffusion" because of the importance of the reaction rate of carbon monoxide with pulmonary capillary blood (see Equation 4 ). Nevertheless, "rate constant for carbon monoxide uptake" is probably the best operational definition for the KCO.
DETERMINANTS OF KCO IN NORMAL SUBJECTS Effect of Lung Volume
As the lung volume decreases from TLC to FRC, the DL CO falls and KCO rises (8, 11) (Figure 2 ). Expressed as a percentage of the value at predicted TLC (zVAmax), DL CO at 50% VAmax is 79%, and KCO is 158% (8) . This increased efficiency of alveolar uptake of carbon monoxide (KCO) at resting breathing volumes protects the DL CO against undue volume dependence, that is, DL CO is 80% of its TLC value at 50% VAmax rather than the expected 50%. The physiological reason for the increase in KCO with decreasing alveolar expansion is given in the Roughton-Forster (12) equation (1/DL ¼ 1/DM 1 1/u$Vc), normalized to VA:
where DM is the membrane diffusing capacity; u bl CO is the reaction rate of carbon monoxide with blood (minute 21 mm Hg
21
), adjusted to a standard hemoglobin (Hb) concentration; and Vc is the pulmonary capillary volume. With a decrease in alveolar expansion, the ratio VA/DM remains almost constant (13) , so the fall in VA/DL CO (¼ rise in KCO) is caused by the decrease in VA/Vc (¼ rise in Vc/VA), with Vc remaining constant as VA decreases (13) . The change in Vc/VA is consistent with the stability of pulmonary blood flow (approximately the cardiac output) during lung volume changes.
Changes on Exercise
During exercise, DL CO (and KCO) rises at constant VA (14) . This was first shown by M. Krogh in 1915 (1) . The reason is that the rise of pulmonary artery (and, to a lesser extent, pulmonary Concise Clinical Reviewvenous) pressure, which accompanies the increase in pulmonary blood flow, distends the pulmonary capillary bed and recruits additional alveolar septal vessels (15) . This increases capillary volume (Vc) and the membrane diffusing capacity (DM) (14) . On exercise at constant VA, Vc/VA increases; DM/VA also increases because vascular distension expands the alveolar surface available for gas exchange. Thus, DL CO /VA (KCO) increases.
With the rebreathing technique, usually used in exercise studies for measuring DL CO (14) , mean VA does not change from rest to exercise (14, 16) , being mostly constrained by the volume of the rebreathing bag, but VA did increase on exercise according to the open-circuit DL CO method (16) ; in this case, the increase in VA would itself contribute to the increase in DL CO , although its effect would be reduced by a fall in KCO accompanying the rise in VA.
Variables That Can Be Controlled
Other factors that influence KCO (but not VA) are anemia and alveolar PO 2 because u bl CO (see Equation 4) decreases as [Hb] falls or as alveolar PO 2 rises. A rise in the steady state PCO in plasma (called the "back-pressure"), due to recent cigarette smoking or multiple preceding measurements of DL CO , also lowers the DL CO . Standard corrections for these three factors are available (9) . The test gas includes 21-25% oxygen (depending on the helium concentration), so KCO is usually measured at a normal alveolar PA O 2 . KCO is greater supine than erect, but clinical measurements are always made in the seated upright posture.
Reference Values
The predictions for DL CO depend on age, sex, and height (17) . Of the components of the DL CO , VA depends on sex and height but not on age, and, in adults, KCO depends inversely on age and height but, in a review of the literature, hardly at all on sex (18) .
The highest values for KCO have been found in boys and girls before the age of puberty (6), suggesting that the pulmonary capillary bed has developed earlier than alveolar volume. The decline in KCO in adults with age may be related to changes in the microvasculature, secondary to the loss of lung elasticity with aging. The inverse relationship with height for KCO may be because the apices of the lungs are less well perfused in the upright position in taller people for gravitational reasons. 
Nomenclature and Units
This review refers to the DL CO as the carbon monoxide diffusing capacity, and uses traditional units (ml and mm Hg). In Europe, the DL CO is termed the "carbon monoxide transfer factor" (TL CO ) and SI units are used for gas uptake (mmol) and pressure (kPa). Divide by 3.0 to convert traditional to SI units.
CHANGES IN KCO AND "ACCESSIBLE" VA IN DISEASE Clinical Causes of Decreases or Increases in KCO
Alveolar and/or microvascular damage and destruction, leading to loss of alveolar or capillary surface area, affecting both DM and Vc, reduce the rate of carbon monoxide uptake per unit volume, leading to a low KCO as a percentage of the predicted value; in some circumstances, KCO may exceed the upper limit of normal at predicted TLC, and this has clinical significance Table 1 [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] ). In relation to increases in KCO, incomplete alveolar expansion, without compromise of alveolar structure, elevates KCO by increasing Vc/VA; a lesser increase in Vc/VA is also largely responsible for the increase in KCO with increases in pulmonary blood flow, either through the whole lung, as in a left-to-right shunt, or through part of the lung, as after a pneumonectomy. The increase in KCO (and also DL CO ) in asthma is probably linked to better perfusion of the apices of the lungs (27) , and this may explain, in part, the increase in KCO in some obese patients, although a raised capillary volume and low DM have been found (33) , suggesting an element of pulmonary vascular congestion as in chronic heart failure (34, 35) .
Diversion of blood flow from a resected lung, for example, pneumonectomy, increases perfusion per unit volume in the remaining lung by 80-100%, depending on the preoperative partitioning of flow between the two lungs, and assuming total pulmonary blood flow (zcardiac output) remains the same postpneumonectomy. This will increase the KCO in the lung that remains. Corris and colleagues (30) established an empirical relationship in 28 patients for the increase in KCO that occurred postpneumonectomy:
where x was the percentage flow (%) to the resected lung, based on a preoperative radioisotope lung perfusion scan. KCO postpneumonectomy was 110-131% predicted (mean KCO preoperatively for both lungs averaged 98%); in the case in which flow to both lungs was equal preoperatively (x ¼ 50%), Equation 5 predicts the KCO in the remaining nonresected lung to increase by 122%, that is, in an average case to 120% predicted (98 1 22%). The reason for this increase in KCO is the expected doubling of blood flow per unit volume in the remaining lung. This DKCO is consistent with the 20% increase in KCO when pulmonary blood flow in normal lungs increases from 5 L minute 21 at rest to 10 L minute 21 on moderate exercise (14) . VA after pneumonectomy averaged 50% of the preoperative value; thus, the remaining lung was expanded to its predicted TLC when the KCO was measured postoperatively. Note that for a similar reduction of overall VA to 50% predicted, but applied to both lungs by underexpansion (e.g., neuromuscular disease), the increase in KCO at 50% VA/ VA TLC is considerably greater (158%: see Figure 2 ) than the 122% occurring postpneumonectomy.
The effect of 50% volume loss from two different causes, (1) reduced alveolar expansion and (2) "loss of units" (pneumonectomy), is illustrated for DL CO in Figure 3A and for KCO in Figure  3B . The difference for KCO in Figure 3B arises from different changes in the two components of the KCO from the RoughtonForster formula (Equation 4), VA/DM and VA/Vc. With restricted alveolar expansion, DM/VA (inverse of VA/DM) and Vc (13) remain relatively constant; hence halving lung volume (to 50% VA/ VA TLC ) will increase Vc/VA to 200% and increase KCO to 158% ( Figure 3B ). After pneumonectomy, the whole cardiac output must be distributed to the remaining lung whose blood flow, per unit volume, probably doubles. A doubling of pulmonary blood flow during moderate exercise in normal subjects increases the KCO to 120%; this arises from changes in both the DM and Vc components of the Roughton-Forster equation: DM/VA increases to 133% and Vc/VA to 141% of their resting values (14) . The larger increase in Vc/VA at 50% VA/VA TLC with underexpansion (200%) compared with exercise (141%), and, by implication, postpneumonectomy may arise because the number of alveoli and alveolar capillaries in two lungs is twice the number postpneumonectomy.
The increase in KCO postpneumonectomy (30) (increased blood flow per unit volume) is a general phenomenon in many lung diseases in which blood flow is redistributed to less diseased areas with an increase in local flow and blood volume per unit alveolar volume; this redistribution may be the explanation for increases in KCO seen occasionally in other conditions in which interstitial or vascular disease, in its early stages, is patchy, leading to blood flow diversion to the remaining normal lung. Thus, a normal or mildly elevated KCO is seen in a proportion of cases with sickle cell disease (36), interstitial lung disease, and sarcoidosis (37) .
Pulmonary hemorrhage (32) , in which blood recently shed from capillaries takes up carbon monoxide, is the one example of a raised KCO that is not linked to an increased rate of alveolarcapillary uptake. KCO is more sensitive than DL CO in detecting pulmonary hemorrhage (38) because of a small accompanying fall in VA. In 39 patients, the maximal increase above baseline averaged 219% for KCO but only 182% for DL CO . In nine patients the peak rise in DL CO was less than 50%, but the rise in KCO above baseline always exceeded 50%.
Clinical Causes of a Low "Accessible" Alveolar Volume (VA)
In the single-breath DL CO , there are three distinct causes of a low VA (as a percentage of VAmax predicted, z93.5% 6 6.6 [1.0 SD] TLC) ( Table 2 ) resulting in different values for the KCO (see Table 1 ):
1. Incomplete alveolar expansion (KCO . 120% predicted).
Loss of lung units (KCO 100-120% predicted).
Besides pneumonectomy, localized destruction of lung 6 fibrosis, infiltration with granulomas or inflammatory exudates, atelectasis, alveolar edema, and pneumonic consolidation are other causes.
3. Poor mixing with maldistribution of inspired gas. This is most obvious in the case of a bulla. But, intrapulmonary airflow obstruction from any of the major causes (emphysema, bronchitis, bronchiolitis, bronchiectasis, asthma) generally lowers the VA/TLC ratio, when VA is measured with 10-second helium dilution and TLC with body plethysmography or multibreath inert gas wash-in or washout (4) . VA, even in normal subjects, is an "accessible" rather than an absolute volume. The KCO is variable and depends on the pathology (Table 2 ). But, clearly there is a continuum in the sense of different values of VA and KCO within a single diagnostic category. These three causes may coexist: causes 1 and 2 in interstitial lung disease, and causes 2 and 3 in COPD or bronchiectasis.
KCO ENHANCES UNDERSTANDING OF DL CO
The DL CO is the product of its two components, KCO and VA (Equation 1). The most compelling argument in favor of the KCO (unadjusted) is set out in Table 3 , where the same value of DL CO (as a percentage of the predicted value) may occur from different combinations of its components (KCO and VA). The combination of low VA and high KCO has a different clinical significance (extrapulmonary restriction) compared with the combination of low KCO and normal VA (microvascular injury), although the DL CO is practically the same.
In chronic inspiratory muscle weakness (28, 39) , the KCO is usually less (120-130%) ( Table 3 , diagnosis A) than that predicted from the decrease of VA (KCO predicted would be 150%; Figure  3B ), presumably due to secondary changes stemming from microatelectasis, retention of secretions, and infection. In interstitial lung disease (Table 3 , diagnosis C), especially preceding the overt fibrotic phase, the KCO may be within the "normal" range (say 80-100%), but in the presence of a low VA, this could be interpreted as "abnormal" because the expected compensation via the "loss of units" model is lacking. In emphysema (in this example) ( Table 3 , diagnosis D) there is relatively little gas mixing deficit after inspiration to TLC, and KCO predicted is less than VA predicted, suggesting disorganization of peripheral airspaces, which remain (mostly) ventilated. This contrasts with Table 3 , diagnosis C, in which the DL CO is similar, but KCO is higher than the VA. This suggests that the disease is more localized with up to 30% of alveolar units destroyed or infiltrated with inflammatory exudate (gas mixing from the VA/TLC ratio [data not shown] is normal), and that the remaining alveolar units are functioning well, even if not entirely normally, as gas exchange units. The analysis adds less in Table 3 , diagnosis E, in which a low DL CO in the presence of normal lung volumes without airflow obstruction suggests straightaway some pulmonary vascular pathology.
CURRENT VIEWS ON DL CO /VA (¼ KCO)
In an earlier section (MEASUREMENT OF KCO AND VA: COMBINING VA AND KCO) we pointed out that current practice reports DL CO , that is, kCO/Pb*; see Equation 2) has led to the idea that DL CO /VA "adjusts" or "corrects" the DL CO when the VA is lower than predicted. Because DL CO /VA (¼ KCO) is not a constant function versus VA (Figures 2 and 3) , several authors (40) (41) (42) have claimed that DL CO /VA has no clinical value, and even that the KCO is an "arithmetically flawed" index (7) (if this were the case, we would expect KCO 3 VA [¼ DL CO ] to share this flaw). The confusion arises from the substitution for KCO of its equivalent (DL CO /VA), which gives the impression of a "volume correction." The ATS/ERS Task Force (9, 10) counsels caution in the use of the DL CO /VA ratio, but nowhere is the connection made that the DL CO /VA is essentially a rate constant, similar to kCO and kCO/Pb* except in its units. It is clear that the nonlinear relationship between KCO and lung volume (Figure 2 ) precludes DL CO /VA from being a "volume correction" for the DL CO when VA is reduced, but KCO remains a true reflection of alveolar CO uptake efficiency at a given volume. In our opinion, the emphasis on DL CO /VA as a correction factor for lung volume is misconceived, and reflects a misapprehension of the physiology. Hence, we believe the term DL CO /VA should be replaced by the more informative term, KCO.
SHOULD THE KCO BE CORRECTED FOR A LOW VA?
Corrections have been proposed on the basis of the relationship in normal subjects between change of lung volume and the change in DL CO /VA (KCO). A typical relationship (data from 24 subjects) is as follows (8):
where DL CO TLC and VA TLC are expected values for DL CO and VA at a normal predicted TLC. For a VA/VA TLC ratio of 0.5, Thus, KCO would be adjusted down at 0.5 VA/VA TLC by multiplying by 0.64 (1/1.57). Johnson (8) studied retrospectively the pulmonary function records of 2,313 patients, and analyzed subgroups of patients with asthma, emphysema, extrapulmonary restriction, interstitial lung disease, and lung resection. Before adjustment, there was wide dispersion between DL CO and KCO (as a percentage of the predicted value), with KCO (%) exceeding DL CO (%) by up to 50%. After adjustment of KCO for a low VA, DL CO and KCO tended to converge. Using a similar approach, Frans and colleagues (43) reported convergence of DL CO and KCO values after adjustment of both for the low VA in diffuse interstitial lung disease. Basically, these "corrections" return a high KCO in extrapulmonary restriction to values in the 90-100% predicted range, and in interstitial lung disease and sarcoidosis they adjust the KCO down from 75-105% predicted to 50-75% predicted, more in line with the uncorrected DL CO . The authors (8, 43) argue that "normal" values for DL CO /VA (unadjusted) in interstitial lung disease give the clinician a "false" impression that the gas-exchanging part of the lung is "healthy." Stam and colleagues (44) studied patients who developed alveolar injury after bleomycin treatment. After bleomycin, the KCO reduction was greater (by up to 11%) if its value was referenced to the KCO at the actual lung volume rather than the predicted TLC. They concluded, like others (8, 43) , that the volume restriction had "misleadingly" increased the KCO. The flaw in the argument is that alveolar restriction by underexpansion is only one of at least three mechanisms causing a low VA (Table 2 ). For example, it is unlikely that the majority of the alveolar units contributing to the KCO in interstitial lung disease, pneumonectomy, or airflow obstruction from various causes are "underexpanded." Hughes and Pride (2) presented corrections for a high KCO and low VA using two models (alveolar underexpansion, and increased pulmonary blood flow; based on Equation 5; see their Table  3 ), but this is hardly a practical solution for the clinician, and does not address the question of low VA caused by poor gas mixing.
It is not unreasonable to seek an interpretation of, or correction for, the DL CO when VA is reduced. For example, it would be legitimate to correct DL CO and KCO, using Equations 6 and 7, for underexpansion of the lung during breath holding (due to extrapulmonary restriction or technical artifact) provided that alveolar deflation was the sole cause of the low VA. Our contention is that any "correction" of the DL CO for volume (VA) must take into account the reason for the volume deficit-for 50% volume loss (VA ¼ 0.5 VA TLC ) DL CO /VA (¼ KCO) will be significantly greater in extrapulmonary restriction than after a pneumonectomy or maldistribution of inspired gas as in bullous emphysema. There is no easy solution to this problem. There is no "correct" way in which the rate constant (kCO z kCO/Pb* z KCO) can be properly adjusted for all the causes of low alveolar 
THE DIFFUSING CAPACITY FOR NITRIC OXIDE (DL NO )
In the last two decades, the measurement of pulmonary diffusing capacity using nitric oxide (DL NO ) has been introduced (45, 46) . DL NO is 4 to 4.5 times greater than DL CO , partly because the physical diffusivity of nitric oxide is about twice that of carbon monoxide, and partly because red cell resistance to nitric oxide uptake is less than that to carbon monoxide (47) owing mostly to the much faster combination (by 280-fold) of nitric oxide with hemoglobin (Hb). Unlike DL CO , DL NO is PO 2 independent (48). The low red cell resistance suggests that DL NO is measuring mostly the diffusive component of the alveolar to red cell transfer pathway, related to the surface area/thickness ratio of the blood gas barrier. Since the work of Roughton and Forster (12) this has been referred to as the membrane diffusing capacity (DM). DM NO is related to the better known DM CO by a (¼ 1.97), the ratio of the physical diffusivities of nitric oxide and carbon monoxide in plasma, that is, DM NO /a ¼ DM CO .
Guenard and colleagues (45) measured DL NO and DL CO simultaneously by the classical single-breath technique. Assuming DM NO /a ¼ DM CO , they showed that the Roughton-Forster formulation (1/DL CO ¼ 1/DM CO 1 1/u bl CO Vc) could be rearranged:
Reasonable values of DM CO and Vc were obtained in normal subjects (45) . Although, for clinical interpretation, DL NO may be regarded as a surrogate for the membrane diffusing capacity (DM), the notion that u bl NO is infinite has been called into question. Measurements of DL NO before and after experimentally induced hemolysis (49) and after blood substitution, in anesthetized dogs, with cell-free heme-based oxyglobin (50) , suggest that DL NO is not entirely "red cell independent." After oxyglobin exchange transfusion, in the red cell-free state, DL NO increased 1.5 times (DL CO did not change), which suggests that DM NO is 1.5 times DL NO rather than its equivalent. It was suggested previously that DL NO might be a surrogate for DL O 2 (51) .
THE DL NO /DL CO RATIO
Because of reservations about the relevance of in vitro measurements of u bl CO and u bl NO to the in vivo situation (49, 50) , interest is shifting from estimates of DM and Vc toward the DL NO /DL CO ratio. Assuming, for clinical purposes, that u bl NO is infinite so that DL NO ¼ DM NO ¼ DM CO $a, and from the Roughton-Forster equation for carbon monoxide (12):
Thus, the DL NO /DL CO ratio is weighted toward the DM/Vc ratio and a (the NO/CO physical solubility ratio). It is also equivalent to the KNO/KCO ratio because DL ¼ K 3 VA, and VA is common to DL NO and DL CO when measured simultaneously by the standard single-breath technique with inhalation of nitric oxide and carbon monoxide. Measurements of the DL NO /DL CO ratio have been performed in normal subjects, at rest and during exercise (53) (54) (55) , and over a range of lung volumes (56, 57) . The DL NO / DL CO ratio has been studied in several clinical situations. For example, the DL NO /DL CO ratio is increased in heavy smokers (58) , otherwise healthy, and in diffuse parenchymal disease (59) and in chronic thromboembolic pulmonary hypertension (59), possibly because Vc/VA is reduced more than DM/VA. In contrast, the DL NO /DL CO ratio is decreased at FRC versus TLC (56), the explanation being that DL NO is more sensitive to alveolar underexpansion than DL CO . For example, from VA TLC to VA 50% TLC the DL NO declines by 43% versus 29% for DL CO (56) . The reason is that the fall in DL CO is buffered by an increase in KCO (135%) whereas KNO (being less influenced by the rise in Vc/VA) increases by only 10% (56) . Thus, the DL NO /DL CO ratio could become a marker for extrapulmonary restriction.
The DL NO /DL CO ratio gives some insights into the components (DM and Vc) of the Roughton-Forster equation in a single maneuver without the two-step approach with carbon monoxide at different alveolar PO 2 as well as by-passing u bl CO , the value of which is somewhat controversial (51, 52) . Experience to date with DM and Vc partitioning has been disappointing because commonly both change equally (the only notable example of discordance [DM↓, Vc↑] being chronic heart failure [34, 35] ); thus, we would expect a low DL NO /DL CO ratio in chronic heart failure, at least in the early stages. It is also possible that by factoring out VA, the DL NO /DL CO ratio (¼ KNO/KCO) may provide additional insight into other respiratory diseases.
CONCLUSIONS
The single-breath DL CO is, physiologically, the product of two simultaneous measurements: the rate of carbon monoxide uptake from alveolar gas to pulmonary capillary blood (kCO), reexpressed per mm Hg alveolar dry gas pressure (Pb*) as kCO/Pb*, and the "accessible" alveolar volume (VA), which approaches, in normal subjects, TLC. kCO/Pb* is linked mathematically to DL CO /VA (¼ KCO). The term DL CO /VA is misleading because, as kCO/Pb*, it reflects the rate of alveolar uptake of CO.
The common causes of a low VA are (1) underexpansion of alveoli in relation to their predicted TLC, (2) loss of alveolar units by destruction or infiltration with exudates or transudates, (3) poor gas mixing and penetration during the 10-second single-breath maneuver, and (4) some combination of cases 1, 2, and 3. Thus, there is no single factor or equation with which the pulmonary function laboratory can "correct" or "adjust" DL CO for all the causes of a low VA, and the use of the term DL CO /VA should be replaced by its alternative, KCO.
Clinical interpretation of a low DL CO (as a percentage of the predicted value) stems from inspection of the components of the DL CO (KCO and VA) and knowledge of physiological principles. From a consideration of the KCO and VA (as a percentage of the predicted value), together with spirometry and lung volume measurements, it should be possible to distinguish emphysema from bronchiectasis, bronchiectasis from asthma, diffuse interstitial lung disease from extrapulmonary restriction, and both from pulmonary microvascular disease.
In the future, the diffusing capacity for nitric oxide (DL NO ) may enable us to focus on alveolar structure differently from the DL CO . The DL NO /DL CO ratio may be a surrogate for the DM/Vc ratio and DL NO may provide information on total barrier (tissue and blood) thickness, largely independent of any chemical resistance introduced by the presence of hemoglobin.
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